Rakuten Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-99,999
Closed -$33M 485
2025
Q4
$33M Buy
99,999
+72,741
+267% +$23.1M 0.11% 61
2025
Q3
$5.09M Buy
+27,258
New +$7.91M 0.02% 245
2025
Q1
$21.1M Buy
+68,832
New +$20.3M 0.1% 52
2024
Q3
$13.8M Buy
42,652
+11,011
+35% +$3.6M 0.08% 42
2024
Q2
$9.93M Buy
31,641
+12,114
+62% +$3.56M 0.07% 45
2024
Q1
$5.55M Buy
19,527
+18,203
+1,375% +$5.33M 0.04% 51
2023
Q4
$382K Buy
+1,324
New +$361K ﹤0.01% 65

Other funds holding AMGN

Rakuten Investment Management's AMGN Position: Q1 2026 in Review

Rakuten Investment Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 99,999 shares — an estimated $33M sold.

Rakuten Investment Management first reported a position in AMGN in Q4 2023 and held it in 7 quarters. The position peaked at $33M in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Rakuten Investment Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Rakuten Investment Management sold 99,999 Amgen shares in Q1 2026, an estimated $33M.
  • Rakuten Investment Management first reported a position in Amgen in Q4 2023 and held it in 7 quarters.
  • Rakuten Investment Management's Amgen position peaked at $33M in Q4 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.